Statistics
Publications
31
Citations
6.8K
H-Index
24
Active since
1989
Peter Wijngaard is an author at Doctors Company (United States) specializing in pharmacology, clinical pharmacology, and medicine.
Publications per year
1989–2022
31
31
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Frederick J. Raal, David Kallend, Kausik K. Ray et al. · New England Journal of Medicine · 2020 · 801 citations · Full text
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald, Suellen White, Anna Borodovsky et al. · New England Journal of Medicine · 2016 · 760 citations · Full text
1–5 of 31